Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
ESMO: Bristol Myers, Roche fail in post-surgery kidney cancer. But is it good news for Merck's Keytruda?
Fierce Pharma
Mon, 09/12/22 - 10:57 am
ESMO
Roche
Bristol Myers Squibb
kidney cancer
Keytruda
Merck
Opdivo
Yervoy
ESMO: Merck's Keytruda chalks up failure in head and neck cancer. But experts see silver lining
Fierce Pharma
Mon, 09/12/22 - 10:52 am
Merck
Keytruda
head and neck cancer
ESMO
ESMO: Seagen's Padcev pulls its weight in combo with Merck's Keytruda
Fierce Pharma
Thu, 09/8/22 - 04:40 pm
Merck
Keytruda
Astellas
Seagen
Padcev
ESMO
urothelial cancer
ESMO 2022 – the new liver cancer entrants line up
EP Vantage
Thu, 09/8/22 - 10:39 am
ESMO
liver cancer
Keytruda
tislelizumab
camrelizumab
Merck
BeiGene
Novartis
ESMO 2022 – Keytruda secures a renal cancer monopoly
EP Vantage
Thu, 09/8/22 - 12:03 am
Merck
Keytruda
renal cancer
Bristol Myers Squibb
Roche
ESMO
Merck's Deal With Seagen May Have Fallen Through. Now What?
Motley Fool
Wed, 09/7/22 - 10:16 am
Merck
Seagen
M&A
Merck and Seagen can't agree on a price for their rumored merger
Fierce Pharma
Fri, 08/26/22 - 10:43 am
M&A
Merck
Seagen
Merck backs radiopharmaceutical startup Aktis, joining other high-profile backers
BioPharma Dive
Thu, 08/25/22 - 10:55 am
Aktis Oncology
radiopharmaceuticals
Merck
Novartis
Bristol Myers Squibb
Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant
Fierce Biotech
Tue, 08/23/22 - 10:32 am
Merck
Bayer
FDA
MK-2060
end-stage renal disease
ESRD
bloodthinners
Merck Makes Another Big R&D Investment with $3.5B Orna Deal
BioSpace
Tue, 08/16/22 - 12:10 pm
Merck
RNA
Orna Therapeutics
oncology
infectious disease
With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2
Fierce Pharma
Mon, 08/15/22 - 10:35 am
earnings
Pfizer
AstraZeneca
Merck
Big Pharma
inflation
supply chain
Ukraine
pandemic
COVID-19
Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe
Yahoo/Zacks.com
Fri, 08/12/22 - 10:12 am
Seagen
Adcetris
Padcev
Tukysa
Tivdak
Merck
M&A
FDA says found possible carcinogen in certain samples of Merck's Januvia
Yahoo/Reuters
Tue, 08/9/22 - 11:51 pm
Merck
Januvia
FDA
diabetes
carcinogens
Merck is back in Alzheimer's saddle with $1B+ Cerevance pact, years after dropping the BACE
Fierce Biotech
Tue, 08/9/22 - 10:42 am
Merck
Cerevance
Alzheimer's disease
R&D
biobucks
Merck plans to count coughs and months until gefapixant is back in FDA hands
Fierce Biotech
Fri, 08/5/22 - 10:54 am
Merck
FDA
gefapixant
chronic cough
Bayer
Merck's Keytruda, on a losing streak, fails in once FDA-rejected liver cancer use and prostate cancer—again
Fierce Pharma
Wed, 08/3/22 - 09:15 pm
Merck
Keytruda
FDA
liver cancer
Lenvima
Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data
Fierce Pharma
Tue, 08/2/22 - 10:54 am
Roche
Pfizer
Merck
Tecentriq
clinical trials
cancer
checkpoint inhibitors
Merck picks up another ADC agreement
Biopharma Reporter
Tue, 08/2/22 - 10:50 am
Merck
antibody-drug conjugate
Sichuan Kelun Pharmaceutical
Drugmakers leap back into fading heart drug market
Beckers Hospital Review
Thu, 07/28/22 - 06:40 pm
Bristol Myers Squibb
Novartis
Merck
Alnylam Pharmaceuticals
Amgen
hypertension
cholesterol
Merck Dives As Drug-Pricing Bills Undercut Second-Quarter Profit
Investors Business Daily
Thu, 07/28/22 - 06:37 pm
Merck
earnings
Keytruda
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »